Table 1.
Surviving cases n (%) | Deceased cases n (%) | |
---|---|---|
Sex | ||
Males | 381 (71) | 250 (84) |
Females | 153 (29) | 48 (16) |
Reference age | ||
<40 | 21 (4) | 2 (1) |
40–55 | 124 (23) | 23 (8) |
55–70 | 295 (55) | 156 (52) |
>70 | 94 (18) | 117 (39) |
Race | ||
White | 517 (97) | 277 (93) |
Non-white | 17 (3) | 21 (7) |
Smoking status | ||
Never | 102 (19) | 39 (13) |
Former | 258 (49) | 149 (52) |
Current | 169 (32) | 101 (35) |
AJCC stage | ||
0a | 321 (61) | 131(45) |
0is | 22 (4) | 9 (3) |
I | 142 (27) | 84 (29) |
II–IV | 40 (8) | 64 (22) |
Grade | ||
1 | 227 (50) | 72 (29) |
2 | 121 (27) | 66 (27) |
3 | 105 (23) | 111 (44) |
Tumor size (mm) | ||
<30 | 467 (87) | 255 (86) |
>30 | 67 (13) | 43 (14) |
Treatment | ||
Surgery | 393 | 194 |
Surgery and immunotherapy | 47 | 38 |
Surgery and radiation/chemotherapy | 12 | 20 |
Radiation/chemotherapy | 5 | 6 |
Data were missing on smoking n = 14, stage n = 19, grade n = 130